Hogan Lovells 2024 Election Impact and Congressional Outlook Report
Nicola Lemay
Partner Corporate & Finance
-
Overview
-
Experience
-
Credentials
-
Insights and events
Nicola Lemay has more than 25 years of experience advising clients on complex domestic and international tax matters. Known for her top-tier analytical, negotiating and drafting skills, Nicola works closely with clients to devise practical and tax-efficient solutions to achieve clients’ business objectives.
Nicola advises clients in respect of domestic and international mergers and acquisitions, restructurings, licensing and other intellectual property transactions, capital raising and deployment strategies, project finance, joint ventures and partnership tax matters. She also represents clients in the development and financing of renewable energy projects, including the structuring of tax credit transactions.
Nicola has successfully represented clients on matters before the Internal Revenue Service and state tax authorities, including in respect of private letter rulings and similar requests for official guidance.
Representative experience
Lantheus Holdings, Inc on a Rule 144A offering of US$575m aggregate principal amount of its 2.625% convertible senior notes due 2027. *
Ginkgo Bioworks on its collaboration with Boehringer Ingelheim in mining Ginkgo’s metagenomic sequence database for a specified number of projects up to an aggregate total of US$406m. *
Ginkgo Bioworks on a collaboration agreement with Merck worth up to US$114m in milestone payments to engineer enzymes for use as biocatalysts. *
Ginkgo Bioworks on its collaboration and licensing agreement with Biogen to develop a next-generation recombinant adeno-associated virus (AAV) production platform. *
GreenLight Biosciences on its US$1.2bn SPAC business combination with Environmental Impact Acquisition Corp., that resulted in GreenLight becoming a publicly listed company. *
The Valens Company Inc., a leading manufacturer of cannabis products, in the acquisition of Green Roads worth up to US$60m. *
Anji Pharmaceuticals Inc., on its domestication from the Cayman Islands to Delaware and in numerous joint venture and licensing transactions. *
Collegium Pharmaceutical, Inc. on its US$525m acquisition of Ironshore Therapeutics Inc.
*Matter handled prior to joining Hogan Lovells.
Credentials
Education
- J.D., Harlan Fiske Stone Scholar, Columbia University School of Law
- M.B.A., Columbia Business School, Dean's List
- B.A., Carleton College, cum laude
Bar admissions and qualifications
- Massachusetts
- New York
Memberships
- Boston Bar Association
- Massachusetts Bar Association
- American Bar Association
- Corporate Tax Committee
- Energy and Environmental Taxes Committee
- Partnerships and LLC Committee
- Project Finance and Development Committee
- North Shore InnoVentures (life sciences and cleantech incubator)
- North Shore Technology Council
- International Fiscal Association
- Co-Chair, Tax Law Section (2007-2009)
- Co-Chair, Federal Tax Law Committee (2005-2007)
Recognition
News
Press releases
07 October 2024
Press releases
25 September 2024
Press releases
23 September 2024